By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Alnara Pharmaceuticals, Inc. 

840 Memorial Drive

Boston  Massachusetts  02139  U.S.A.
Phone: 617-349-3690 Fax: 617-349-3696


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Eli Lilly and Company (LLY) Pays up to $380M for Alnara Pharmaceuticals, Inc. 7/21/2010 7:10:52 AM
Eli Lilly and Company (LLY) To Buy Drug Developer Alnara Pharmaceuticals, Inc. 7/6/2010 7:18:25 AM
Alnara Pharmaceuticals, Inc. Flourishes from Altus Pharmaceuticals Inc. (ALTU) Demise 3/5/2010 7:17:45 AM
Alnara Pharmaceuticals, Inc. Secures $35 Million in Series B Round 1/28/2010 6:37:29 AM
Alnara Pharmaceuticals, Inc. Announces Appointment of Lee R. Brettman, M.D., FACP, to Chief Medical Officer 11/3/2009 9:28:11 AM
Lonza Group Ltd. and Alnara Pharmaceuticals, Inc. Enter into Manufacturing Agreement to Produce Liprotamase 10/21/2009 1:41:00 PM
Long-Term Data from Landmark Phase 3 Safety and Nutritional Study Evaluating Alnara Pharmaceuticals, Inc.' Liprotamase in Patients with CF to be Presented at 2009 North American Cystic Fibrosis Conference 10/5/2009 9:40:11 AM
Alnara Pharmaceuticals, Inc. Announces Promotion of Robert Gallotto to Chief Business Officer 4/16/2009 8:51:44 AM
Alnara Pharmaceuticals, Inc. Licenses Worldwide Rights to Liprotamase from Cystic Fibrosis Foundation 3/25/2009 9:14:54 AM
Alnara Pharmaceuticals, Inc. Secures $20 Million in Series A Round 10/30/2008 6:28:14 AM
//-->